Cargando…

Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021

Campylobacter fetus accounts for 1% of Campylobacter spp. infections, but prevalence of bacteremia and risk for death are high. To determine clinical features of C. fetus infections and risks for death, we conducted a retrospective observational study of all adult inpatients with a confirmed C. fetu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zayet, Souheil, Klopfenstein, Timothée, Gendrin, Vincent, Vuillemenot, Jean-baptiste, Plantin, Julie, Toko, Lynda, Sreiri, Nour, Royer, Pierre-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617355/
https://www.ncbi.nlm.nih.gov/pubmed/37877803
http://dx.doi.org/10.3201/eid2911.230598
_version_ 1785129592986533888
author Zayet, Souheil
Klopfenstein, Timothée
Gendrin, Vincent
Vuillemenot, Jean-baptiste
Plantin, Julie
Toko, Lynda
Sreiri, Nour
Royer, Pierre-Yves
author_facet Zayet, Souheil
Klopfenstein, Timothée
Gendrin, Vincent
Vuillemenot, Jean-baptiste
Plantin, Julie
Toko, Lynda
Sreiri, Nour
Royer, Pierre-Yves
author_sort Zayet, Souheil
collection PubMed
description Campylobacter fetus accounts for 1% of Campylobacter spp. infections, but prevalence of bacteremia and risk for death are high. To determine clinical features of C. fetus infections and risks for death, we conducted a retrospective observational study of all adult inpatients with a confirmed C. fetus infection in Nord Franche-Comté Hospital, Trevenans, France, during January 2000–December 2021. Among 991 patients with isolated Campylobacter spp. strains, we identified 39 (4%) with culture-positive C. fetus infections, of which 33 had complete records and underwent further analysis; 21 had documented bacteremia and 12 did not. Secondary localizations were reported for 7 (33%) patients with C. fetus bacteremia, of which 5 exhibited a predilection for vascular infections (including 3 with mycotic aneurysm). Another 7 (33%) patients with C. fetus bacteremia died within 30 days. Significant risk factors associated with death within 30 days were dyspnea, quick sequential organ failure assessment score >2 at admission, and septic shock.
format Online
Article
Text
id pubmed-10617355
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-106173552023-11-01 Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021 Zayet, Souheil Klopfenstein, Timothée Gendrin, Vincent Vuillemenot, Jean-baptiste Plantin, Julie Toko, Lynda Sreiri, Nour Royer, Pierre-Yves Emerg Infect Dis Synopsis Campylobacter fetus accounts for 1% of Campylobacter spp. infections, but prevalence of bacteremia and risk for death are high. To determine clinical features of C. fetus infections and risks for death, we conducted a retrospective observational study of all adult inpatients with a confirmed C. fetus infection in Nord Franche-Comté Hospital, Trevenans, France, during January 2000–December 2021. Among 991 patients with isolated Campylobacter spp. strains, we identified 39 (4%) with culture-positive C. fetus infections, of which 33 had complete records and underwent further analysis; 21 had documented bacteremia and 12 did not. Secondary localizations were reported for 7 (33%) patients with C. fetus bacteremia, of which 5 exhibited a predilection for vascular infections (including 3 with mycotic aneurysm). Another 7 (33%) patients with C. fetus bacteremia died within 30 days. Significant risk factors associated with death within 30 days were dyspnea, quick sequential organ failure assessment score >2 at admission, and septic shock. Centers for Disease Control and Prevention 2023-11 /pmc/articles/PMC10617355/ /pubmed/37877803 http://dx.doi.org/10.3201/eid2911.230598 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Synopsis
Zayet, Souheil
Klopfenstein, Timothée
Gendrin, Vincent
Vuillemenot, Jean-baptiste
Plantin, Julie
Toko, Lynda
Sreiri, Nour
Royer, Pierre-Yves
Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021
title Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021
title_full Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021
title_fullStr Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021
title_full_unstemmed Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021
title_short Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021
title_sort campylobacter fetus invasive infections and risks for death, france, 2000–2021
topic Synopsis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617355/
https://www.ncbi.nlm.nih.gov/pubmed/37877803
http://dx.doi.org/10.3201/eid2911.230598
work_keys_str_mv AT zayetsouheil campylobacterfetusinvasiveinfectionsandrisksfordeathfrance20002021
AT klopfensteintimothee campylobacterfetusinvasiveinfectionsandrisksfordeathfrance20002021
AT gendrinvincent campylobacterfetusinvasiveinfectionsandrisksfordeathfrance20002021
AT vuillemenotjeanbaptiste campylobacterfetusinvasiveinfectionsandrisksfordeathfrance20002021
AT plantinjulie campylobacterfetusinvasiveinfectionsandrisksfordeathfrance20002021
AT tokolynda campylobacterfetusinvasiveinfectionsandrisksfordeathfrance20002021
AT sreirinour campylobacterfetusinvasiveinfectionsandrisksfordeathfrance20002021
AT royerpierreyves campylobacterfetusinvasiveinfectionsandrisksfordeathfrance20002021